Dhule, India

Mahendra Patil Raghunath

This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Generics Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahendra Patil Raghunath. Retrieved from https://idiyas.com/inventor/mahendra-patil-raghunath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahendra Patil Raghunath: Innovator in Pharmaceutical Chemistry

Introduction

Mahendra Patil Raghunath, based in Dhule, India, is a notable inventor with a patent in the field of pharmaceutical chemistry. His innovative work has contributed significantly to the development of novel drug formulations.

Latest Patents

Raghunath holds a patent for "Palonosetron free base and process for its preparation." This invention presents a novel palonosetron free base available in both amorphous and crystalline forms. Furthermore, it details processes for preparing palonosetron hydrochloride derived from the newly developed palonosetron free base.

Career Highlights

Mahendra Patil Raghunath currently works at Glenmark Generics Limited, a prominent player in the pharmaceutical industry. His role involves the formulation of innovative drug solutions that aim to improve patient care and treatment efficacy.

Collaborations

Raghunath has collaborated with talented colleagues such as Mubeen Ahmad Khan and Prashant Yadav Kundlik. Together, they work towards advancing pharmaceutical technologies and developing new solutions for healthcare challenges.

Conclusion

Mahendra Patil Raghunath is a significant figure in pharmaceutical innovations, with a focused determination to enhance drug formulations. His contributions through his patent reflect a commitment to improving therapeutic options available to patients, reinforcing the vital role of inventors in advancing the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…